What is the lead time for large orders?

For orders greater than 5 units, the lead time is to be negotiated.

What is the packaging method?

The device is packaged in wooden crates or cartons.

What are the main applications of this pump?

It is designed for laparoscopic gynecology and urology procedures.

Touch Screen Medical Grade CO2 Insufflator for Laparoscopic Surgery

Name: Touch Screen Medical Grade CO2 Insufflator for Laparoscopic Surgery
Brand: Xuzhou Hengjia Electronic Technology Co., Ltd.
SKU: 2299803835

Jiangsu, ChinaXuzhou Hengjia Electronic Technology Co., Ltd.

US$900.00-1,400.00

1 Piece

Sample price:US$990.00/piece.Request sample

Product profile

Customization

Available

Classification

Physiological Functions of Diagnosis and Monitoring Equipment

Type

CO2 Insufflator

Certification

CE, FDA, ISO13485, RoHS

Group

Middle-aged and Old

Screen

Touch Screnn

Gas Flow

30L / 50L

Working Pressure Range

1-25mmhg

Gas

Medical Grade CO2

Working Flow Range

1-50mmhg

Transport Package

Carton

Specification

metal

Trademark

GEIWRE

Origin

China

HS Code

3203964268

Key features

Touch Screen Interface: Features an LCD touch screen for intuitive operation and sensitive feedback.

Pulse Gas Supply: Provides pulse gas supply that is more real and direct for better clinical results.

Multiple Gas Flow Options: Available in 30L, 40L, and 50L gas flow rates to suit different needs.

Wide Pressure Range: Operating pressure range of 0-25mmhg for precise control during procedures.

Medical Grade CO2: Designed to work specifically with medical grade CO2 gas.

Comprehensive Certifications: Certified by CE, FDA, ISO13485, and RoHS for safety and compliance.

Fast Delivery for Small Orders: Estimated lead time of 7 days for orders of 1 to 5 units.

Versatile Medical Application: Ideal for laparoscopic gynecology and urology procedures.

Company profile

Xuzhou Hengjia Electronic Technology Co., Ltd.

Jiangsu, China

Business Type: Manufacturer/FactoryExport Year: 2012-12-01Average Response Time: ≤3.67h

AI-Powered supplier vetting

SummaryXuzhou Hengjia Electronic Technology Co., Ltd. is identified as a Chinese manufacturer/factory producing medical devices, including endoscopy systems, laparoscope towers, monitors, light sources, insufflators, and related equipment. The supplier reports ISO 13485 and ISO 9001 certifications, more than 10 production lines, 6–10 R&D engineers, and 6–10 quality-control staff. It began exporting in 2012, with exports representing 51%–70% of total sales. The company reports 41 medical software copyrights, 5 invention patents, 6 new product invention patents, and 8 medical information privacy-protection invention patents. Its stated customer base includes secondary, tertiary, and top-tier hospitals, but no specific customer names or independently verifiable case details are provided. After-sales capability, customization capability, financial credibility, and actual production volume remain insufficiently documented.

Supplier typeThe supplier is explicitly described as a manufacturer/factory and as a company engaged in the production, development, management, and sales of medical devices. Its listed business activities include health and medicine, instruments and meters, and electrical and electronic products.

CertificationsThe supplier reports holding ISO 13485 and ISO 9001 management-system certifications. ISO 13485 is directly relevant to medical-device quality management, while ISO 9001 indicates a general quality-management certification.

R&D capabilityThe supplier describes a high-tech and innovation-oriented approach and reports 41 medical software copyrights, 5 invention patents, 6 new product invention patents, and 8 medical information privacy-protection invention patents. These stated intellectual-property achievements provide explicit evidence of product and software development capability.

Production capacityThe supplier is identified as a factory/manufacturer with more than 10 production lines and a broad medical-device product portfolio. Its reported export activity and stated company scale expansion further support operating capability, although actual capacity utilization, output quantities, and manufacturing equipment details are not provided.